Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai — New York, New York

Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Progressive Supranuclear Palsy.

Sponsors: Ferrer Internacional S.A..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai?

Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai conducted?

Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai has 1 clinical trials on record, with 1 currently active. Their work covers Progressive Supranuclear Palsy.

Is Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai accredited by Crixeo Health?

Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.